Janux Therapeutics

1 follower

Janux Therapeutics is developing safe, effective novel immunotherapies with the company’s proprietary TRACTr technology. Janux’s TRACTr technology employs a modular design to rapidly engineer drug candidates against specific targets.

Industries

Employees

51-200

Links


Org chart

David Campbell
President & CEO
Collapse
Tighe Reardon
Acting CFO
Byron Robinson
Chief Strategy Officer
Carolina Caffaro
Vice President, CMC
Sara Walsh
Executive Administrative Assistant to the President and Chief Executive Officer
James Pennington
General Counsel
Mandie Forman-Sklansky
Executive Director, Head Of HR
Janeen Doyle
Chief Corporate And Business Development Officer
Sandy Seril
Executive Assistant
Jenna Daly
Executive Director Clinical Operations
Megan Shannon
Executive Director, Clinical Science
William Go MD
Chief Medical Officer
Kevin Watt
Vice President, Program and Portfolio Management

Board & advisors

Jay Lichter
Chairperson
Vickie Capps
Director
Jake Simson
Director
Greg Weiss
Advisor
Ron Barrett
Director
Winston Kung
Director